North Bay company looks for 2nd rare-disease drug approval, voucher in 5 months

Winning FDA approval of a rare disease drug for children would net the company a voucher, which it could use to accelerate FDA review of another drug or sell to the highest bidder for millions of dollars.

Source: bizjournals.com Health Care:Biotechnology headlines - April 16, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news